Circulating anticoagulant (antifactor 8 treated with immunosuppressive drugs.
D000328:Adult; D000925:Anticoagulants / Q000097:blood*; D001379:Azathioprine / Q000627:therapeutic use; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000209:etiology; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D005169:Factor VIII / Q000037:antagonists & inhibitors; D005260:Female; D006400:Hematocrit; D006406:Hematoma / Q000175:diagnosis; D006505:Hepatitis / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D009583:Nitrofurazone / Q000009:adverse effects; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications; D065227:Transfusion Reaction
D000925:Anticoagulants; D007166:Immunosuppressive Agents; D005169:Factor VIII; D015122:Mercaptopurine; D001379:Azathioprine; D011241:Prednisone; D009583:Nitrofurazone